Home/Pipeline/TAGSS Pyloroplasty

TAGSS Pyloroplasty

Gastroparesis

Pre-clinicalActive

Key Facts

Indication
Gastroparesis
Phase
Pre-clinical
Status
Active
Company

About Endo-TAGSS

Endo-TAGSS is a private, pre-revenue medical device company founded in 2016 and based in San Diego, CA, USA. Its core technology is the TAGSS device, a 12mm trans-abdominal gastric port system intended to bridge the gap between endoscopy and laparoscopy, allowing for more complex intragastric surgeries with fewer incisions and potentially lower costs. The company is in the pre-clinical stage, having demonstrated proof-of-concept in animal models for applications like pyloroplasty and fundoplication, but its devices are not yet FDA-cleared for sale.

View full company profile